GI
NUVB icon

GAMMA Investing’s Nuvation Bio NUVB Stock Holding History

GAMMA Investing’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18K Sell
207
-203
-50% -$992 ﹤0.01% 3843
2026
Q1 		$1.76K Sell
410
-406
-50% -$2.26K ﹤0.01% 3706
2025
Q4 		$7.31K Buy
+816
New +$5.05K ﹤0.01% 3118

Other funds holding NUVB

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
FWP
Firethorn Wealth Partners Augusta, Georgia $310M AUM 23.22% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing's NUVB Position: Q2 2026 in Review

GAMMA Investing reduced its Nuvation Bio (NUVB) stake by 50% in Q2 2026, selling an estimated $992 and leaving 207 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #3843.

GAMMA Investing first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.31K in Q4 2025. 13 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • GAMMA Investing held 207 shares of Nuvation Bio worth $1.18K as of Q2 2026.
  • GAMMA Investing sold 203 Nuvation Bio shares in Q2 2026, an estimated $992.
  • Nuvation Bio made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3843 holding.
  • GAMMA Investing first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • GAMMA Investing's Nuvation Bio position peaked at $7.31K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.